Price T Rowe Associates Inc Glaukos Corp Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Glaukos Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 30,955 shares of GKOS stock, worth $4.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,955
Previous 32,636 5.15%
Holding current value
$4.73 Million
Previous $3.86 Million 4.4%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$113.62 - $135.39 $190,995 - $227,590
-1,681 Reduced 5.15%
30,955 $4.03 Million
Q2 2024

Aug 14, 2024
BUY
$89.48 - $118.35 $203,298 - $268,891
2,272 Added 7.48%
32,636 $3.86 Million
Q1 2024

May 15, 2024
SELL
$76.4 - $96.33 $21.7 Million - $27.3 Million
-283,560 Reduced 90.33%
30,364 $2.86 Million
Q4 2023

Feb 14, 2024
BUY
$59.53 - $85.11 $17.1 Million - $24.5 Million
287,736 Added 1098.73%
313,924 $25 Million
Q3 2023

Nov 14, 2023
BUY
$69.23 - $79.09 $3,392 - $3,875
49 Added 0.19%
26,188 $1.97 Million
Q2 2023

Aug 14, 2023
BUY
$45.44 - $71.21 $33,125 - $51,912
729 Added 2.87%
26,139 $1.86 Million
Q1 2023

May 15, 2023
SELL
$43.88 - $52.48 $219,531 - $262,557
-5,003 Reduced 16.45%
25,410 $1.27 Million
Q4 2022

Feb 14, 2023
BUY
$40.82 - $57.75 $24,696 - $34,938
605 Added 2.03%
30,413 $1.33 Million
Q3 2022

Nov 14, 2022
BUY
$46.84 - $58.49 $183,472 - $229,105
3,917 Added 15.13%
29,808 $1.59 Million
Q2 2022

Aug 15, 2022
BUY
$34.86 - $63.77 $39,008 - $71,358
1,119 Added 4.52%
25,891 $1.18 Million
Q1 2022

May 16, 2022
BUY
$44.33 - $57.82 $81,877 - $106,793
1,847 Added 8.06%
24,772 $1.43 Million
Q4 2021

Feb 14, 2022
SELL
$40.27 - $56.99 $27,665 - $39,152
-687 Reduced 2.91%
22,925 $1.02 Million
Q3 2021

Nov 15, 2021
SELL
$47.43 - $84.23 $40,647 - $72,185
-857 Reduced 3.5%
23,612 $1.14 Million
Q2 2021

Aug 16, 2021
BUY
$73.06 - $97.7 $76,201 - $101,901
1,043 Added 4.45%
24,469 $2.08 Million
Q1 2021

May 17, 2021
SELL
$70.43 - $97.42 $12,677 - $17,535
-180 Reduced 0.76%
23,426 $1.97 Million
Q4 2020

Feb 16, 2021
BUY
$48.9 - $75.26 $1.15 Million - $1.78 Million
23,606 New
23,606 $1.78 Million

Others Institutions Holding GKOS

# of Institutions
341
Shares Held
46.8M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.27B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email